Outbreak details

Cruise line: Aida Cruises

Cruise ship: AIDAdiva

Voyage dates: November 10, 2025–December 16, 2025 

Voyage number: DI40251110 

Date outbreak reported to VSP: November 30, 2025

Number of passengers who reported being ill during the voyage out of total number of passengers onboard: 95 of 2,007 (4.8%)

Number of crew who reported being ill during the voyage out of total number of crew onboard: 6 of 640 (0.9%)

Predominant symptoms: diarrhea, vomiting 

Causative agent: norovirus

Actions taken in response

In response to the outbreak, Aida Cruises and the crew aboard the ship reported the following actions: 

  • Increased cleaning and disinfection procedures according to their outbreak prevention and response plan
  • Collected stool specimens from gastrointestinal illness cases for testing
  • Isolated ill passengers and crew
  • Consulted with VSP about sanitation cleaning procedures and reporting ill cases

VSP is remotely monitoring the situation, including review of the ship’s outbreak response and sanitation procedures. 

Tips for healthy cruising

Learn how passengers can protect themselves.

More information

Gastrointestinal (GI) illness is a commonly used term for acute gastroenteritis (AGE). Reporting gastrointestinal illness is important. When passengers and crew tell the medical center onboard about their symptoms, it helps GI illness outbreaks get detected quickly. This allows steps to be taken to limit the spread of illness. Medical staff evaluate symptoms to see if they meet our case definition for AGE:

  • Three or more loose stools within a 24-hour period or what is more than normal for that person OR
  • Vomiting along with one of the following symptoms: diarrhea, muscle ache, headache, abdominal cramp, or fever

Cruise ships are required to report these cases to us. 

Note: Cases reported are totals for the entire voyage. It does not mean all people are sick at the same time, such as when they arrive or leave a port or ship. 

Learn more about AGE monitoring and how VSP responds to AGE outbreaks.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Ilana Korchia Ilana Korchia

Ilana joined Marler Clark in May 2019, after graduating from the University of Florida with her bachelor’s degree in food science. She maintained her role at Marler Clark while pursuing her law degree at Seattle University School of Law, graduating Cum Laude in…

Ilana joined Marler Clark in May 2019, after graduating from the University of Florida with her bachelor’s degree in food science. She maintained her role at Marler Clark while pursuing her law degree at Seattle University School of Law, graduating Cum Laude in 2022. Presently, as an attorney at Marler Clark, her responsibilities encompass drafting pleadings, motions, and demand letters, overseeing discovery processes, handling litigation, and conducting extensive research on diverse legal and scientific matters across numerous cases undertaken by the firm. Ilana has previous experience as a public affairs intern at the Food and Drug Administration (FDA). She is originally from Nice in the south of France. In her spare time, she enjoys reading, traveling, cooking, and hiking.